Michael Nabity, MD
Obstetrics & Gynecology · Omaha, NENPI 1124172663
Payments from drug & device makers
Across 103 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$377
- Bayer$177
- Organon$177
- Sumitomo Pharma America, Inc.$155
- Mayne Pharma Commercial LLC$117
- Coopersurgical, Inc.$115
- plus $792 from 20 others
What the payments were for
- Food & beverage$1,84897%
- Education$613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $377 |
| Bayer | 10 | $177 |
| Organon | 8 | $177 |
| Sumitomo Pharma America, Inc. | 7 | $155 |
| Mayne Pharma Commercial LLC | 7 | $117 |
| Coopersurgical, Inc. | 6 | $115 |
| Astellas Pharma US Inc | 4 | $107 |
| Biogen | 5 | $99 |
| Hologic Sales And Service, LLC | 5 | $82 |
| Pfizer | 6 | $78 |
| Exeltis, USA Inc. | 4 | $62 |
| Merck | 1 | $56 |
| Daiichi Sankyo Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $38 |
| Novo Nordisk | 2 | $36 |
| Therapeuticsmd, Inc. | 2 | $31 |
| Baxter Healthcare | 1 | $18 |
| Minerva Surgical, Inc | 1 | $18 |
| KARL Storz Endoscopy-america | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Alydia Health | 1 | $16 |
| Myovant Sciences Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Duchesnay USA Incorporated | 1 | $12 |
How this compares
$1,909 in reported general payments places this provider in the 70th percentile of 242 obstetrics & gynecology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 41 | $1,171 |
| Clobetasol Propionate | 14 | $247 |
| Fluconazole | 24 | $186 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Omaha
- John CoteOmaha$236K
- Jimmy KhandalavalaOmaha$32K
- Robin ClemmerOmaha$19K
- Susan UlmerOmaha$8K
- Jennifer CeraOmaha$5K
- Trevor WatsonOmaha$5K
- Jamie SeemanOmaha$4K
- Malorie HoweOmaha$4K
- Sonya TranOmaha$3K
- Jessica Prusa FloresOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.